# Dan Patrick Adds Data Centers, Prediction Markets, and THC to Senate Priorities > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/texas-medical-cannabis-patient-access-thc-policy/ > **Published:** 2026-04-05T13:01:57-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:30:05-04:00 > **Clinical Summary:** Explore Texas medical cannabis patient access and THC policy updates impacting treatment pathways and legislative priorities in 2026. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyTexas[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Patient AccessThc Why This Matters Texas legislative priorities on THC policy directly impact patient access to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) in the nation’s second-largest state. Policy changes at the state level create or eliminate treatment pathways for patients with qualifying conditions who may benefit from [cannabinoid therapy](https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/). Clinical Summary Texas Lieutenant Governor Dan Patrick has included THC regulation among legislative priorities, though specific policy directions remain undefined. Texas currently maintains restrictive medical cannabis laws through its Compassionate Use Program, limiting access to low-THC products for select conditions. Any legislative changes could expand or further restrict patient access to cannabinoid treatments in a state where millions of patients currently have limited legal options. Dr. Caplan’s Take “Without knowing the specific policy direction, this is either promising news for patient access or concerning news for clinical care — the devil is entirely in the implementation details that haven’t been revealed yet.” Clinical Perspective 🧠 Clinicians treating patients in Texas should monitor legislative developments closely, as changes could significantly impact treatment options. Patients currently accessing care through existing programs should maintain continuity while staying informed about potential policy shifts that could affect their legal protections or access pathways. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%20and%20THC%20to%20Senate%20priorities%20-...%20%40drcaplan&url=https%3A//www.corsicanadailysun.com/news/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/article_fd1f5d93-834c-441f-b61e-1b8d8e573c62.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.corsicanadailysun.com/news/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/article_fd1f5d93-834c-441f-b61e-1b8d8e573c62.html)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%20and%20THC%20to%20Senate%20priorities%20-...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.corsicanadailysun.com/news/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/article_fd1f5d93-834c-441f-b61e-1b8d8e573c62.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.corsicanadailysun.com/news/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/article_fd1f5d93-834c-441f-b61e-1b8d8e573c62.html](https://www.corsicanadailysun.com/news/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/article_fd1f5d93-834c-441f-b61e-1b8d8e573c62.html) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis policy development?](#What_is_the_clinical_relevance_rating_for_this_cannabis_policy_development) - [What type of cannabis policy is being discussed?](#What_type_of_cannabis_policy_is_being_discussed) - [Why is this development considered clinically relevant?](#Why_is_this_development_considered_clinically_relevant) - [What geographic area does this policy affect?](#What_geographic_area_does_this_policy_affect) - [How should healthcare providers respond to this information?](#How_should_healthcare_providers_respond_to_this_information) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis policy development? This development has been assigned CED Clinical Relevance #70, which indicates “Notable Clinical Interest.” This rating suggests emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What type of cannabis policy is being discussed? This appears to be related to medical cannabis policy developments in Texas. The focus seems to be on patient access issues within the state’s medical cannabis program. #### Why is this development considered clinically relevant? The rating indicates this involves emerging findings or policy changes that could impact patient care. Healthcare providers should monitor these developments as they may affect treatment options and patient access to medical cannabis. #### What geographic area does this policy affect? This policy development specifically affects Texas. Any changes to Texas medical cannabis policies would impact patients and healthcare providers within the state. #### How should healthcare providers respond to this information? Given the “Notable Clinical Interest” rating, healthcare providers should stay informed about these policy developments. This is particularly important for clinicians who may treat patients who could benefit from medical [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/). [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Dan Patrick adds data centers, prediction markets and THC to Senate priorities | KVEO-TV](https://cedclinic.com/texas-senate-cannabis-legislative-priorities-update-2026/) Detailed coverage of Dan Patrick's legislative priorities including THC and its implications for Texas medical cannabis policy. [Read More](https://cedclinic.com/texas-senate-cannabis-legislative-priorities-update-2026/) [Dan Patrick adds data centers, prediction markets, THC to Senate priorities](https://cedclinic.com/texas-senate-data-centers-legislative-priorities-2026/) An overview of the Senate priorities focusing on data centers, prediction markets, and THC regulation in Texas. [Explore Article](https://cedclinic.com/texas-senate-data-centers-legislative-priorities-2026/) [Dan Patrick adds data centers, prediction markets and THC to Senate priorities – Yahoo](https://cedclinic.com/texas-medical-cannabis-access-barriers-senate-priorities/) Analysis of challenges facing the Texas medical cannabis program amid new Senate priorities including THC policy. [Learn More](https://cedclinic.com/texas-medical-cannabis-access-barriers-senate-priorities/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).